{
  "round": 4,
  "request": {
    "reason": "多个假设均面临显著的慢性病理条件相关风险且缺乏机制连接性，需引入更具直接治疗适应症的药物候选。",
    "n": 4
  },
  "prev_hypotheses": [
    "Acitretin",
    "Adalimumab",
    "Apremilast",
    "Brodalumab",
    "Etanercept",
    "Guselkumab",
    "Infliximab",
    "Ixekizumab",
    "Methotrexate",
    "Secukinumab",
    "Tildrakizumab",
    "Ustekinumab"
  ],
  "status": "regenerated",
  "generated_seeds": [
    "Acitretin",
    "Adalimumab",
    "Etanercept",
    "Infliximab",
    "Secukinumab",
    "Ixekizumab",
    "Austedo",
    "Methotrexate",
    "Cyclosporine",
    "Tildrakizumab",
    "Brodalumab",
    "Ustekinumab"
  ],
  "new_hypotheses": [
    "Acitretin",
    "Adalimumab",
    "Etanercept",
    "Infliximab",
    "Secukinumab",
    "Ixekizumab",
    "Austedo",
    "Methotrexate",
    "Cyclosporine",
    "Tildrakizumab",
    "Brodalumab",
    "Ustekinumab"
  ]
}